Juntao Cui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juntao Cui has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Jingzhi Leng
2 shared publications- Junxia Xie
Institute of Brain Science and Disease, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao 266071, China
2 shared publications - Bingjing Wang
School of Basic Medicine, Qingdao University, Qingdao, China
1 shared publication Chunsheng Zhao
1 shared publication- Danyang Zhang
School of Basic Medicine, Qingdao University, Qingdao 266071, China
1 shared publication - Di Zhao
Institute of Brain Science and Disease, Shandong Provincial Collaborative Innovation Center for Neurodegenerative Disorders, Shandong Provincial Key Laboratory of Pathogenesis and Prevention of Neurological Disorders, Qingdao University, Qingdao 266021, China
1 shared publication
Latest Publications
- Open Access
- 2 August 2026
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 21, 433-440
Biological mechanisms of different exercise modalities in improving sleep disorders: A review
- 2 August 2026
- Published by Elsevier in IBRO Neuroscience Reports
- Vol. 21, 433-440
Open AccessBiological mechanisms of different exercise modalities in improving sleep disorders: A review
- Open Access
- 9 July 2026
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 17, 1871149
Caffeine and human performance: from molecular mechanisms to exercise and recovery
Caffeine, the world’s most widely consumed psychoactive substance, is a well-established ergogenic aid. Its performance-enhancing effects are mediated through multiple, interacting mechanisms that follow a dose-dependent hierarchy. The primary and most significant action at common dietary doses is the antagonism of central adenosine A 1 and A 2a receptors. This central blockade reduces perceived effort and fatigue, increases arousal, and modulates pain perception, thereby lowering the neural cost of exercise. This central effect is complemented by secondary peripheral metabolic actions, such as the promotion of lipolysis, though their role as primary drivers in exercising humans is supported mainly by experimental models. A direct effect on skeletal muscle calcium handling occurs only at supra-physiological concentrations and is not relevant in practice. The integration of these mechanisms leads to significant but task-dependent performance outcomes. The most robust and consistent benefits are observed for aerobic endurance exercise. Effects on strength, power, and high-intensity intermittent performance are more variable and are largely mediated by neurological and perceptual factors, explaining their greater consistency in protocols involving fatigue. For sports requiring cognitive skill, caffeine reliably enhances reaction time, vigilance, and accuracy via central nervous system stimulation. The ergogenic response is highly individualized, shaped by a complex interplay of dose, timing, genetics, and habitual use. Furthermore, preliminary evidence suggests caffeine may modulate post-exercise recovery by potentially accelerating muscle glycogen resynthesis when co-ingested with carbohydrates and by improving muscle perfusion. However, leveraging any potential recovery benefit necessitates extremely careful timing to avoid sleep disruption, as protecting sleep quality is a paramount recovery priority. Future research should develop sport- and context-specific protocols, clarify long-term adaptations, and advance personalized strategies that integrate genetic, habitual, and temporal factors to maximize benefits and minimize adverse effects, reinforcing caffeine’s role as a cornerstone of evidence-based sports nutrition.
- 9 July 2026
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 17, 1871149
Open AccessCaffeine and human performance: from molecular mechanisms to exercise and recovery
Caffeine, the world’s most widely consumed psychoactive substance, is a well-established ergogenic aid. Its performance-enhancing effects are mediated through multiple, interacting mechanisms that follow a dose-dependent hierarchy. The primary and most significant action at common dietary doses is the antagonism of central adenosine A 1 and A 2a receptors. This central blockade reduces perceived effort and fatigue, increases arousal, and modulates pain perception, thereby lowering the neural cost of exercise. This central effect is complemented by secondary peripheral metabolic actions, such as the promotion of lipolysis, though their role as primary drivers in exercising humans is supported mainly by experimental models. A direct effect on skeletal muscle calcium handling occurs only at supra-physiological concentrations and is not relevant in practice. The integration of these mechanisms leads to significant but task-dependent performance outcomes. The most robust and consistent benefits are observed for aerobic endurance exercise. Effects on strength, power, and high-intensity intermittent performance are more variable and are largely mediated by neurological and perceptual factors, explaining their greater consistency in protocols involving fatigue. For sports requiring cognitive skill, caffeine reliably enhances reaction time, vigilance, and accuracy via central nervous system stimulation. The ergogenic response is highly individualized, shaped by a complex interplay of dose, timing, genetics, and habitual use. Furthermore, preliminary evidence suggests caffeine may modulate post-exercise recovery by potentially accelerating muscle glycogen resynthesis when co-ingested with carbohydrates and by improving muscle perfusion. However, leveraging any potential recovery benefit necessitates extremely careful timing to avoid sleep disruption, as protecting sleep quality is a paramount recovery priority. Future research should develop sport- and context-specific protocols, clarify long-term adaptations, and advance personalized strategies that integrate genetic, habitual, and temporal factors to maximize benefits and minimize adverse effects, reinforcing caffeine’s role as a cornerstone of evidence-based sports nutrition.
- Open Access
- 1 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (18) , eaec6955
Piezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson’s disease
Traditional deep-brain stimulation via implanted electrodes can effectively treat neurological disorders, but surgical injury limits its clinical application. Here, we developed ultrasound-responsive piezoelectric nanoparticles for minimal-invasive and wireless neuromodulation. In the 6-OHDA–induced Parkinson’s disease (PD) mouse model, these nanoparticles are injected into the subthalamic nucleus (STN) of the mouse brain. After ultrasound stimulation for several days, the motor behavior, particularly gait abnormalities and nonmotor symptoms such as pain and anxiety, in PD mice is alleviated without detectable toxicity. The piezoelectric nanoparticles can activate the STN area of the mouse after ultrasound stimulation. Our results demonstrate that piezoelectric-mediated neuromodulation of the STN reverses motor deficits in PD by modulating neural signals, thereby protecting dopaminergic neurons and enhancing levels of the neurotransmitter dopamine. This process can rescue and mitigate mitochondrial dysfunction and neuroinflammation in the nigrostriatal pathway. Our approach enables STN neuronal activation with minimal invasiveness, offering a promising strategy for treating neurodegenerative diseases.
- 1 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (18) , eaec6955
Open AccessPiezoelectric neuromodulation of the subthalamic nucleus ameliorates motor and nonmotor symptoms of Parkinson’s disease
Traditional deep-brain stimulation via implanted electrodes can effectively treat neurological disorders, but surgical injury limits its clinical application. Here, we developed ultrasound-responsive piezoelectric nanoparticles for minimal-invasive and wireless neuromodulation. In the 6-OHDA–induced Parkinson’s disease (PD) mouse model, these nanoparticles are injected into the subthalamic nucleus (STN) of the mouse brain. After ultrasound stimulation for several days, the motor behavior, particularly gait abnormalities and nonmotor symptoms such as pain and anxiety, in PD mice is alleviated without detectable toxicity. The piezoelectric nanoparticles can activate the STN area of the mouse after ultrasound stimulation. Our results demonstrate that piezoelectric-mediated neuromodulation of the STN reverses motor deficits in PD by modulating neural signals, thereby protecting dopaminergic neurons and enhancing levels of the neurotransmitter dopamine. This process can rescue and mitigate mitochondrial dysfunction and neuroinflammation in the nigrostriatal pathway. Our approach enables STN neuronal activation with minimal invasiveness, offering a promising strategy for treating neurodegenerative diseases.
- Open Access
- 18 December 2021
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 19 (1) , 1-29
Regulated cell death: discovery, features and implications for neurodegenerative diseases
Regulated cell death (RCD) is a ubiquitous process in living organisms that is essential for tissue homeostasis or to restore biological balance under stress. Over the decades, various forms of RCD have been reported and are increasingly being found to involve in human pathologies and clinical outcomes. We focus on five high-profile forms of RCD, including apoptosis, pyroptosis, autophagy-dependent cell death, necroptosis and ferroptosis. Cumulative evidence supports that not only they have different features and various pathways, but also there are extensive cross-talks between modes of cell death. As the understanding of RCD pathway in evolution, development, physiology and disease continues to improve. Here we review an updated classification of RCD on the discovery and features of processes. The prominent focus will be placed on key mechanisms of RCD and its critical role in neurodegenerative disease.Graphical Abstract
- 18 December 2021
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 19 (1) , 1-29
Open AccessRegulated cell death: discovery, features and implications for neurodegenerative diseases
Regulated cell death (RCD) is a ubiquitous process in living organisms that is essential for tissue homeostasis or to restore biological balance under stress. Over the decades, various forms of RCD have been reported and are increasingly being found to involve in human pathologies and clinical outcomes. We focus on five high-profile forms of RCD, including apoptosis, pyroptosis, autophagy-dependent cell death, necroptosis and ferroptosis. Cumulative evidence supports that not only they have different features and various pathways, but also there are extensive cross-talks between modes of cell death. As the understanding of RCD pathway in evolution, development, physiology and disease continues to improve. Here we review an updated classification of RCD on the discovery and features of processes. The prominent focus will be placed on key mechanisms of RCD and its critical role in neurodegenerative disease.Graphical Abstract